SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001628280-22-016596
Filing Date
2022-06-08
Accepted
2022-06-08 16:43:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 vallon424warrantshares.htm 424B3 210199
2 backcover1aa.jpg GRAPHIC 17489
3 logoa.jpg GRAPHIC 28984
  Complete submission text file 0001628280-22-016596.txt   275470
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-265302 | Film No.: 221003992
SIC: 2834 Pharmaceutical Preparations